Skip to main content
. 2022 Dec 1;9(12):1885. doi: 10.3390/children9121885
ADME Absorption, distribution, metabolism, and excretion
ANDA Abbreviated new drug application
API Active pharmaceutical ingredient
BLA Biologics license application
BPCA Best Pharmaceuticals for Children Act of 2002
CGMP Current Good Manufacturing Practice
CINV-MEC Chemotherapy-induced nausea and vomiting
CRL Complete response letter
DQSA Drug Quality and Security Act of 2013
FDAMA Food and Drug Administration Modernization Act of 1998
IND Investigational new drug
NCE New chemical entity
NDA New drug application
NICHD National Institute for Child Health and Human Development
NME New molecular entity
PK Pharmacokinetic
PREA Pediatric Research Equity Act of 2003
PRV Rare Pediatric Disease Priority Review Voucher Program of 2012
PSP Pediatric study plan
RCT Randomized clinical trial
sNDA Supplementary NDA
US-FDA United States Food and Drug Administration